CHRW
56
5
VMC
33
3
F
39
3
GRMN
46
3
D
50
2
LMT
40
13
BBY
50
-2
JCI
46
4
GPC
38
3
RHI
44
4
FOXA
67
3
AVY
39
2
HBAN
54
3
PPL
49
2
SRE
49
4
EIX
58
-3
EW
46
10
VFC
50
-4
BEN
36
4
TROW
43
8
CHRW
56
5
VMC
33
3
F
39
3
GRMN
46
3
D
50
2
LMT
40
13
BBY
50
-2
JCI
46
4
GPC
38
3
RHI
44
4
FOXA
67
3
AVY
39
2
HBAN
54
3
PPL
49
2
SRE
49
4
EIX
58
-3
EW
46
10
VFC
50
-4
BEN
36
4
TROW
43
8
Financhill
Back

Kissei Pharmaceutical 10K Form

Buy
66

KSPHF
Kissei Pharmaceutical

Last Price:
$25.00
Seasonality Move:
-1.95%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive KSPHF News And Ratings

See the #1 stock for the next 7 days that we like better than KSPHF

KSPHF Financial Statistics

Sales & Book Value

Annual Sales: $523.8M
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $32.89
Price / Book: 0.72

Profitability

EPS (TTM): 1.79110
Net Income (TTM): $80.1M
Gross Margin: $258.8M
Return on Equity: 5.51%
Return on Assets: 4.96%

Kissei Pharmaceutical Earnings Forecast

Key Kissei Pharmaceutical Financial Ratios

  • The Gross Profit Margin over the past 20 years for KSPHF is 49.41%.
  • The Interest Expense is 0.16% of Operating Income.
  • The Net Earning history of KSPHF is 14.77% of Total Revenues.
  • Per Share Earnings over the last 20 years have been positive in 12 years.

Kissei Pharmaceutical Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: KSPHF
Website: kissei.co.jp

Debt

Debt-to-Equity Ratio: 0.01
Current Ratio: 5.92
Quick Ratio: 4.22

Price-to-Earnings

Trailing P/E Ratio: 14.63
Forward P/E Ratio: 0

KSPHF Technical Analysis vs Fundamental Analysis

Buy
66
Kissei Pharmaceutical (KSPHF) is a Buy

Is Kissei Pharmaceutical a Buy or a Sell?